Tenax Therapeutics (TENX) Competitors $5.61 +0.05 (+0.90%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends TENX vs. CLSD, ENTX, IKNA, IMAB, ELYM, GBIO, HOWL, OVID, PYRGF, and FBLGShould you be buying Tenax Therapeutics stock or one of its competitors? The main competitors of Tenax Therapeutics include Clearside Biomedical (CLSD), Entera Bio (ENTX), Ikena Oncology (IKNA), I-Mab (IMAB), Eliem Therapeutics (ELYM), Generation Bio (GBIO), Werewolf Therapeutics (HOWL), Ovid Therapeutics (OVID), PyroGenesis Canada (PYRGF), and FibroBiologics (FBLG). These companies are all part of the "pharmaceutical products" industry. Tenax Therapeutics vs. Clearside Biomedical Entera Bio Ikena Oncology I-Mab Eliem Therapeutics Generation Bio Werewolf Therapeutics Ovid Therapeutics PyroGenesis Canada FibroBiologics Tenax Therapeutics (NASDAQ:TENX) and Clearside Biomedical (NASDAQ:CLSD) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, media sentiment, earnings, institutional ownership, dividends, community ranking, analyst recommendations, valuation and risk. Which has better earnings & valuation, TENX or CLSD? Tenax Therapeutics has higher earnings, but lower revenue than Clearside Biomedical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTenax TherapeuticsN/AN/A-$7.71MN/AN/AClearside Biomedical$7.70M8.59-$32.49M-$0.45-1.94 Do analysts rate TENX or CLSD? Tenax Therapeutics currently has a consensus price target of $16.00, indicating a potential upside of 185.20%. Clearside Biomedical has a consensus price target of $5.33, indicating a potential upside of 511.41%. Given Clearside Biomedical's higher probable upside, analysts clearly believe Clearside Biomedical is more favorable than Tenax Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tenax Therapeutics 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 3.20Clearside Biomedical 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is TENX or CLSD more profitable? Tenax Therapeutics has a net margin of 0.00% compared to Clearside Biomedical's net margin of -413.83%. Clearside Biomedical's return on equity of 0.00% beat Tenax Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Tenax TherapeuticsN/A -46.00% -42.65% Clearside Biomedical -413.83%N/A -92.90% Does the MarketBeat Community believe in TENX or CLSD? Clearside Biomedical received 224 more outperform votes than Tenax Therapeutics when rated by MarketBeat users. Likewise, 67.28% of users gave Clearside Biomedical an outperform vote while only 56.03% of users gave Tenax Therapeutics an outperform vote. CompanyUnderperformOutperformTenax TherapeuticsOutperform Votes14456.03% Underperform Votes11343.97% Clearside BiomedicalOutperform Votes36867.28% Underperform Votes17932.72% Does the media prefer TENX or CLSD? In the previous week, Clearside Biomedical had 4 more articles in the media than Tenax Therapeutics. MarketBeat recorded 5 mentions for Clearside Biomedical and 1 mentions for Tenax Therapeutics. Clearside Biomedical's average media sentiment score of 0.65 beat Tenax Therapeutics' score of 0.00 indicating that Clearside Biomedical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tenax Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Clearside Biomedical 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility & risk, TENX or CLSD? Tenax Therapeutics has a beta of 2.21, meaning that its stock price is 121% more volatile than the S&P 500. Comparatively, Clearside Biomedical has a beta of 2.29, meaning that its stock price is 129% more volatile than the S&P 500. Do insiders and institutionals have more ownership in TENX or CLSD? 1.7% of Tenax Therapeutics shares are owned by institutional investors. Comparatively, 18.8% of Clearside Biomedical shares are owned by institutional investors. 3.7% of Tenax Therapeutics shares are owned by insiders. Comparatively, 9.2% of Clearside Biomedical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. SummaryClearside Biomedical beats Tenax Therapeutics on 11 of the 16 factors compared between the two stocks. Ad Insiders ExposedHas Trump Finally Gone Too Far?Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover Get Tenax Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TENX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TENX vs. The Competition Export to ExcelMetricTenax TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$19.12M$6.57B$5.13B$9.08BDividend YieldN/A2.99%4.93%4.22%P/E RatioN/A10.5589.5817.18Price / SalesN/A195.351,115.01116.87Price / CashN/A57.1642.8237.86Price / Book0.215.104.804.78Net Income-$7.71M$151.51M$120.04M$225.60M7 Day Performance-4.59%-2.12%-1.91%-1.23%1 Month Performance15.67%-3.10%11.48%3.36%1 Year Performance-76.70%11.54%30.59%16.59% Tenax Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TENXTenax Therapeutics1.4593 of 5 stars$5.61+0.9%$16.00+185.2%-76.7%$19.12MN/A0.009News CoverageCLSDClearside Biomedical2.8771 of 5 stars$1.05+2.9%$5.33+407.9%-12.8%$79.63M$8.23M-2.2930News CoverageENTXEntera Bio1.4305 of 5 stars$2.21+2.3%$10.00+352.5%+195.8%$79.07M$130,000.00-8.3120IKNAIkena Oncology2.8725 of 5 stars$1.62-1.8%$3.00+85.2%-20.5%$78.18M$659,000.00-1.3470IMABI-Mab2.5162 of 5 stars$0.95-4.9%$8.00+741.0%-38.9%$77.52M$3.27M0.0034Gap DownELYMEliem TherapeuticsN/A$2.60-7.8%N/A-27.5%$77.36MN/A-4.9120GBIOGeneration Bio2.7569 of 5 stars$1.15-1.3%$7.50+555.0%-30.0%$76.48M$18.58M-0.53150Positive NewsHOWLWerewolf Therapeutics3.757 of 5 stars$1.69+2.1%$12.00+612.1%-44.8%$75.10M$3.39M-1.0840Positive NewsOVIDOvid Therapeutics4.3809 of 5 stars$1.05+1.9%$4.04+284.8%-71.8%$74.56M$390,000.000.0060Positive NewsPYRGFPyroGenesis CanadaN/A$0.41-1.3%N/A+15.9%$74.54M$9.14M-6.8490FBLGFibroBiologics1.8353 of 5 stars$2.13-4.1%$13.00+510.3%N/A$73.82MN/A0.0010Positive News Related Companies and Tools Related Companies Clearside Biomedical Alternatives Entera Bio Alternatives Ikena Oncology Alternatives I-Mab Alternatives Eliem Therapeutics Alternatives Generation Bio Alternatives Werewolf Therapeutics Alternatives Ovid Therapeutics Alternatives PyroGenesis Canada Alternatives FibroBiologics Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TENX) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tenax Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tenax Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
